These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

98 related articles for article (PubMed ID: 6687998)

  • 1. Reductive fragmentation of 2-nitroimidazoles in the presence of nitroreductases--glyoxal formation from misonidazole.
    Raleigh JA; Liu SF
    Biochem Pharmacol; 1983 Apr; 32(8):1444-6. PubMed ID: 6687998
    [No Abstract]   [Full Text] [Related]  

  • 2. Reduction of misonidazole and its derivatives by xanthine oxidase.
    Josephy PD; Palcic B; Skarsgard LD
    Biochem Pharmacol; 1981 Apr; 30(8):849-53. PubMed ID: 6894696
    [No Abstract]   [Full Text] [Related]  

  • 3. Detection of a reactive metabolite of misonidazole in hypoxic mammalian cells.
    Varghese AJ; Whitmore GF
    Radiat Res; 1984 Feb; 97(2):262-71. PubMed ID: 6538047
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Misonidazole-glutathione conjugates in CHO cells.
    Varghese AJ; Whitmore GF
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1341-5. PubMed ID: 6540764
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reductive activation of nitroaromatics and enzyme inhibition: misonidazole and xanthine oxidase.
    Raleigh JA; Liu SF; Shum FY
    Int J Radiat Oncol Biol Phys; 1982; 8(3-4):701-4. PubMed ID: 6896706
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular and chemical reduction products of misonidazole.
    Varghese AJ; Whitmore GF
    Chem Biol Interact; 1981 Aug; 36(2):141-51. PubMed ID: 7273240
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Binding to cellular macromolecules as a possible mechanism for the cytotoxicity of misonidazole.
    Varghese AJ; Whitmore GF
    Cancer Res; 1980 Jul; 40(7):2165-9. PubMed ID: 6155991
    [TBL] [Abstract][Full Text] [Related]  

  • 8. In vitro metabolism of misonidazole.
    Josephy PD; Palcic B; Skarsgard LD
    Br J Cancer; 1981 Apr; 43(4):443-50. PubMed ID: 7236487
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Metabolism induced binding of 14C-misonidazole to hypoxic cells: kinetic dependence on oxygen concentration and misonidazole concentration.
    Koch CJ; Stobbe CC; Baer KA
    Int J Radiat Oncol Biol Phys; 1984 Aug; 10(8):1327-31. PubMed ID: 6469755
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sulphydryls, ascorbate and oxygen as modifiers of the toxicity and metabolism of misonidazole in vitro.
    Taylor YC; Rauth AM
    Br J Cancer; 1980 Jun; 41(6):892-900. PubMed ID: 7426314
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Binding of misonidazole to hypoxic cells in monolayer and spheroid culture: evidence that a side-chain label is bound as efficiently as a ring label.
    Raleigh JA; Franko AJ; Koch CJ; Born JL
    Br J Cancer; 1985 Feb; 51(2):229-35. PubMed ID: 3966980
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitroimidazoles as anaerobic electron acceptors for xanthine oxidase.
    Clarke ED; Goulding KH; Wardman P
    Biochem Pharmacol; 1982 Oct; 31(20):3237-42. PubMed ID: 6897358
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characteristics of the metabolism-induced binding of misonidazole to hypoxic mammalian cells.
    Chapman JD; Baer K; Lee J
    Cancer Res; 1983 Apr; 43(4):1523-8. PubMed ID: 6831401
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A comparison of the tumour concentrations obtainable with misonidazole and Ro 03-8799.
    Dische S; Saunders MI; Bennett MH; Dunphy EP; Des Rochers C; Stratford MR; Minchinton AI; Wardman P
    Br J Radiol; 1986 Sep; 59(705):911-7. PubMed ID: 3756388
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure-function dependence and allopurinol inhibition of radiosensitizer/nitroreductase interaction: approaches to improving therapeutic ratios.
    Raleigh JA; Shum FY; Koziol DR; Saunders WM
    Cancer Clin Trials; 1980; 3(1):55-62. PubMed ID: 6771029
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Factors influencing intracellular uptake and radiosensitization by 2-nitroimidazoles in vitro.
    Brown DM; Gonzalez-Mendez R; Brown JM
    Radiat Res; 1983 Mar; 93(3):492-505. PubMed ID: 6856754
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Influence of heat on the intracellular uptake and radiosensitization of 2-nitroimidazole hypoxic cell sensitizers in vitro.
    Brown DM; Cohen MS; Sagerman RH; Gonzalez-Mendez R; Hahn GM; Brown JM
    Cancer Res; 1983 Jul; 43(7):3138-42. PubMed ID: 6850622
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of lipophilicity on the rate of diffusion of sensitizers into cellular targets.
    Kandaiya S
    Singapore Med J; 1985 Feb; 26(1):49-52. PubMed ID: 4023724
    [No Abstract]   [Full Text] [Related]  

  • 19. Radiation-enhanced cytotoxicity of misonidazole.
    Korbelik M; Palcic B; Skarsgard LD
    Radiat Res; 1981 Nov; 88(2):343-53. PubMed ID: 7302140
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of the xanthine oxidase inhibitor allopurinol on the renal clearance of nitroimidazoles.
    Workman P; White RA
    Biochem Pharmacol; 1982 Oct; 31(19):3041-6. PubMed ID: 6897355
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.